Dartmon CD19 Antibody (DA127)
IHC (FFPE)
Description
CD19 is present in both normal and malignant B-cells and has long been considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, mantle zone cells, and scattered cells in the interfollicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, CD19 is also expressed in immature B-cells; although recent studies have described CD19 loss in a few B-cell neoplasms.1-3 — Références — 1. Kimura M, et al. Int J Hematol. 2007; 85:41-8. 2. Masir N, et al. Histopathology. 2006; 48:239-46. 3. Greenberg SA, et al. Neurology. 2005; 65:1782-7.
Caractéristiques
- Type
- Recombinant monoclonal rabbit antibody
- Clone
- DA127
- Isotype
- Rabbit
- Réactivité
- Synthetic peptide of human CD19
- Localisation
- Cell membrane
- Usage prévu
- IHC (FFPE)
Conditionnements disponibles
2 référence(s) catalogue.
| N° catalogue | Type | Dilution | Volume | |
|---|---|---|---|---|
| DMRDB145 | Concentrate | 1:25 – 1:75 | 0.1ml, 0.5ml, 1ml | Demander un devis → |
| DMRDB145 | Ready to use | 1:25 – 1:75 | 3ml, 6ml, 10ml | Demander un devis → |
Intéressé par ce produit ?
Indiquez la référence et le conditionnement souhaités, nous revenons vers vous rapidement.